학술논문
Infection Risk and Use of Prophylaxis with Anti-BCMA Bispecific T Cell Engagers and Belantamab Mafodotin for Patients with Relapsed and Refractory Multiple Myeloma
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15280020